Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G23267-20 | 20 µg | $336 |
| LS-G23267-100 | 100 µg | $446 |
| LS-G23267-1 | 1 mg | $1,460 |
Human Coronavirus OC43 SARS-CoV Spike Glycoprotein (Recombinant 6His, N-terminus) (aa15-344) - LS-G23267
Human Coronavirus OC43 SARS-CoV Spike Glycoprotein (Recombinant 6His, N-terminus) (aa15-344) - LS-G23267
Description:
SARS-CoV Spike Glycoprotein LS-G23267 is a Recombinant Human Coronavirus OC43 SARS-CoV Spike Glycoprotein produced in Yeast aa 15-344 with 6His, N-terminus tag(s). For Research Use Only
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
SARS-CoV Spike Glycoprotein LS-G23267 is a Recombinant Human Coronavirus OC43 SARS-CoV Spike Glycoprotein produced in Yeast aa 15-344 with 6His, N-terminus tag(s). For Research Use Only
Specifications
Type
Recombinant Protein
Target
SARS-CoV Spike Glycoprotein
Synonyms
E2 | S E2 glycoprotein | E2 glycoprotein precursor | S
Species
Human Coronavirus OC43
Modifications
Unmodified
Conjugations
Unconjugated
Tag
6His, N-terminus
Region
aa 15-344
Predicted Molecular Weight
39.6 kD
AA Sequence
VIGDLKCTSDNINDKDTGPPPISTDTVDVTNGLGTYYVLDRVYLNTTLFLNGYYPTSGSTYRNMALKGSVLLSRLWFKPPFLSDFINGIFAKVKNTKVIKDRVMYSEFPAITIGSTFVNTSYSVVVQPRTINSTQDGDNKLQGLLEVSVCQYNMCEYPQTICHPNLGNHRKELWHLDTGVVSCLYKRNFTYDVNADYLYFHFYQEGGTFYAYFTDTGVVTKFLFNVYLGMALSHYYVMPLTCNSKLTLEYWVTPLTSRQYLLAFNQDGIIFNAEDCMSDFMSEIKCKTQSIAPPTGVYELNGYTVQPIADVYRRKPNLPNCNIEAWLNDK
Expression System
Yeast
Source Species
Yeast
Bio-Activity
Not Tested
Endotoxin
Not Tested
Presentation
Lyophilized from PBS, 6% Trehalose, pH 7.4.
Reconstitution
Briefly centrifuge vial prior to opening. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Add 5-50% of glycerol (final concentration).
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20-80°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
About SARS-CoV Spike Glycoprotein
Publications (0)
Customer Reviews (0)
Images
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/23/2024
Date Requested: 11/23/2024
